Find information on thousands of medical conditions and prescription drugs.

Retrolental fibroplasia

Retinopathy of prematurity (ROP), also known as retrolental fibroplasia (RLF), is a disease of the eye that affects prematurely born babies. It is thought to be caused by disorganised growth of retinal blood vessels resulting in scarring and retinal detachment. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
Gastroesophageal reflux...
Rabies
Radiophobia
Rasmussen's encephalitis
Raynaud's phenomenon
Reactive arthritis
Reactive hypoglycemia
Reflex sympathetic...
Regional enteritis
Reiter's Syndrome
Renal agenesis
Renal artery stenosis
Renal calculi
Renal cell carcinoma
Renal cell carcinoma
Renal cell carcinoma
Renal failure
Renal osteodystrophy
Renal tubular acidosis
Repetitive strain injury
Respiratory acidosis
Restless legs syndrome
Retinitis pigmentosa
Retinoblastoma
Retinoschisis
Retrolental fibroplasia
Retroperitoneal fibrosis
Rett syndrome
Reye's syndrome
Rh disease
Rhabdomyolysis
Rhabdomyosarcoma
Rheumatic fever
Rheumatism
Rheumatoid arthritis
Rickets
Rift Valley fever
Ringworm
Rocky Mountain spotted fever
Romano-Ward syndrome
Roseola infantum
Rubella
Rubeola
Rubinstein-Taybi syndrome
Rumination disorder
S
T
U
V
W
X
Y
Z
Medicines

ROP can be mild and may resolve spontaneously, but may lead to blindness in serious cases. Oxygen toxicity may contribute to the development of ROP.

International Classification of Retinopathy of Prematurity (ICROP)

The system used for described the findings of ROP is entitled, The International Classification of Retinopathy of Prematurity (ICROP). ICROP "demarcated the location of the disease into zones (1, 2, and 3) of the retina, the extent of the disease based on the clock hours (1-12), and the severity of the disease into stages (0-5)" .

Symptoms and prognosis

In preterm infants, the retina is often not fully formed. ROP occurs when abnormal tissue forms between the central and peripheral retina. There are 5 progressive stages to ROP. Stage 1 is mild and may resolve on its own without severe vision loss; stage 5 is severe and usually results in retinal detachment.

Multiple factors can determine how fast a patient progresses through the stages, including overall health, birth weight, the stage of ROP at initial diagnosis, and the presence or absence of "plus" disease. "Plus" disease occurs when the abnormal vessels in the retina invade other areas of the eye, greatly increasing the risk of retinal detachment.

The abnormal vessel growth often subsides spontaneously, but can progress to retinal detachment and vision loss in patients with extremely low birth weight. Patients with ROP are at greater risk for glaucoma, cataracts and myopia later in life, and should be examined yearly to help prevent and treat these conditions.

Treatment

  • Cryotherapy
  • "Indirect laser"
  • scleral buckle and/or vitrectomy may be considered for severe ROP with retinal detachment

Read more at Wikipedia.org


[List your site here Free!]


Ambient-light exposure and retinopathy of prematurity - Tips From Other Journals
From American Family Physician, 9/1/98 by Jeffrey T. Kirchner

Retinopathy of prematurity is a disease of the developing retinal vasculature that occurs in premature infants and is a leading cause of childhood blindness. The pathogenesis of this disorder is controversial but is believed to be environmental. High levels of inspired oxygen and ambient-light exposure cause an increase in free radicals in the retina, which may increase the incidence of retinopathy in premature infants. The effect of light on this disease has been debated for many years. Reynolds and colleagues performed a prospective, randomized, multicenter study to assess the effect of ambient light on the incidence of retinopathy in premature infants.

The study originally included 409 infants who had a birth weight of less than 1,251 g (2 lb, 12 oz), a gestational age at birth of less than 31 weeks and admission to a neonatal intensive care unit within 24 hours of birth. Children with a lethal congenital anomaly or a major congenital abnormality of one or both eyes were excluded from the study. The newborns were randomly assigned to a control group or a group that received light-reducing goggles within 24 hours after birth. The goggles reduced exposure to visible light by 97 percent and to ultraviolet light by 100 percent. Infants in the control group were exposed to the usual amount of light in the neonatal intensive care unit. The infants in the treatment group wore the goggles until 31 weeks after conception or four weeks after birth, whichever was longer. This length of time was chosen so that the goggles would be removed before it became necessary to identify children who had developed severe eye disease and would require surgical intervention.

After the goggles were removed, all infants had an initial ophthalmologic examination within seven days. They were then examined biweekly until their eyes were fully vascularized or, if retinopathy developed, until they reached 44 weeks' postconception age. A final ophthalmologic examination was performed on all infants six months after term. The ophthalmologists were blinded to treatment-group assignment.

During the study period, 46 infants died and two infants were lost to follow-up, leaving 188 infants in the treatment group and 173 in the control group. The baseline characteristics of both groups were essentially the same. The goggles were worn a median of 28 days. The mean light level measured adjacent to the infants' faces was 447 lux for the control group and 399 lux for the treatment group. There were 102 infants (54 percent) with confirmed retinopathy in the treatment group and 100 infants (58 percent) with confirmed retinopathy in the control group. At the six-month examination, myopia was diagnosed in 31 infants (19 percent) in the treatment group and 28 infants (19 percent) in the control group. All other ocular findings were similar between the two groups at the six-month visit.

The authors conclude that reduction in ambient-light exposure in the neonatal intensive care unit does not reduce the frequency of retinopathy of prematurity in newborns at high risk for this disorder.

Reynolds JD, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity N Engl J Med May 28, 1998;338:1572-6.

COPYRIGHT 1998 American Academy of Family Physicians
COPYRIGHT 2000 Gale Group

Return to Retrolental fibroplasia
Home Contact Resources Exchange Links ebay